To include your compound in the COVID-19 Resource Center, submit it here.

Politics, Policy & Law

PhRMA sues Minnesota, says law requiring free insulin has ‘staggering’ implications

PhRMA has sued the state of Minnesota to block implementation of the Alec Smith Insulin Affordability Act, a law that requires manufacturers to provide insulin free to thousands of state residents. If allowed to stand,...

Grassley pushing drug pricing bill, exchanges barbs with Wyden

Sen. Chuck Grassley (R-Iowa) Monday accused Democrats of “walking away from” drug pricing legislation, while Sen. Ron Wyden (D-Ore.) refuted the allegation, saying that Democrats hadn’t walked away because “Republicans never showed up in the...

WHO seeks $18 billion for COVID-19 vaccines advanced market commitments

A coalition of global health organizations led by the WHO Friday publicly released plans for a global COVID-19 vaccine purchasing pool that is intended to ensure that priority populations around the world have access to...

Trump administration’s challenge to Affordable Care Act casts shadow over biosimilars pathway

By requesting that the Supreme Court invalidate the entire Affordable Care Act, the Trump administration has put into play the biosimilars pathway and other parts of the law that are unrelated to core healthcare coverage...

Illumina, BGI litigation not yet at risk of getting drawn into U.S.-China dispute

Despite the high-profile nature of the patent dispute between Illumina and Chinese competitor BGI Genomics, two of the largest players in next-generation sequencing, there is no reason to believe it will become embroiled in the...

U.K. accepting applications for subscription-based antibiotic pilot

NHS England is calling for biopharmas to apply for a contract to supply an antibiotic via the U.K.’s pilot subscription program, which will pay manufacturers a flat annual rate over 10 years for access to...

Scientists warn Trump immigration ‘pause’ will harm biopharma innovation

President Donald Trump’s decision to bar most employment-based visas through year-end could have a broad impact on the U.S. biopharma industry, which is heavily dependent on temporary and permanent immigrants to fill jobs from junior...

As deadline approaches, Senate introduces voucher program renewal bill

With three months left until Congress’ deadline to reauthorize the rare pediatric disease Priority Review voucher program, two senators introduced legislation late last week to make the program permanent. FDA awards a voucher upon the...

Protecting the world: global access to COVID-19 vaccines

Biopharmaceutical companies and academic scientists around the world have set aside commercial and professional rivalries to collaborate on the development of vaccines to protect against COVID-19. Technologies that have been slowly advancing for a decade...

House lawmakers call for transparency, independent review for COVID-19 vaccine program

A trio of Democrats on the House Oversight Committee are asking FDA for more information on how the agency plans to evaluate and deploy COVID-19 vaccines, in an effort to ensure the process is transparent,...

Juneteenth and our path forward: Letter from BioCentury’s Co-Founders

Editor’s Note: BioCentury’s co-founders, Chairman Karen Bernstein, Ph.D., and President & CEO David Flores, have written to the company’s employees about BioCentury’s response to racism and racial inequities in healthcare. It is published in its...

Sens. Grassley, Durbin push drug price disclosure bill in wake of court ruling

In response to a court decision overturning mandatory disclosures of drug pricing in television ads, Sens. Chuck Grassley and Dick Durbin are pushing legislation that would achieve similar goals. On Tuesday, the U.S. Court of...

Global health funders plan to buy 15 billion COVID-19 vaccine doses

The Access to COVID-19 Tools Accelerator plans to make advance purchase commitments for more than 15 billion doses of COVID-19 vaccines over six years, starting with 1.1 billion in 2021. The accelerator is a collaboration...

Momentum builds for equitable procurement of COVID-19 vaccines as EU lays out strategy

The push to secure supplies of COVID-19 vaccines gathered more steam Wednesday with the European Commission launching an EU-wide procurement strategy to ensure equitable access to COVID-19 vaccines in Europe. The initiative is separate from...

COVAX created to try to avoid global bidding frenzy for COVID-19 vaccines

Panic buying of vaccines by high income countries, mopping up supply and squeezing out lower income countries, is the nightmare postscript to COVID-19 that international health agencies envisage could play out if steps aren’t taken...